We are studying whether high-flow oxygen can help reduce acute dystonic and plegic attacks in children with alternating hemiplegia. The trial also looks at the impact on quality of life for both patients and caregivers.
Health conditions and diseases that the clinical trial is designed to study and treat.
Alternating Hemiplegia of Childhood (AHC) is a rare neurological disorder that causes recurrent episodes of paralysis on one side of the body, which can switch sides. These episodes can be accompanied by other symptoms such as developmental delays and movement disorders.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.
Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.